Cargando…

High Fatty Liver Index and Fracture Risk: Clinical Implications

Detalles Bibliográficos
Autor principal:	Hong, Namki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840914/ https://www.ncbi.nlm.nih.gov/pubmed/36636884 http://dx.doi.org/10.5009/gnl220533

Ejemplares similares

Relationship between the High Fatty Liver Index and Risk of Fracture
por: Kim, Min-Ji, et al.
Publicado: (2023)

Comments on Relationship between the High Fatty Liver Index and Risk of Fracture
por: Lai, Shih-Wei, et al.
Publicado: (2023)

Comments on Relationship between the High Fatty Liver Index and Risk of Fracture: Reply
por: Kim, Min-Ji, et al.
Publicado: (2023)

Implications of comorbidities in nonalcoholic fatty liver disease
por: Song, Sherlot Juan, et al.
Publicado: (2023)

Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
por: Jung, Han Na, et al.
Publicado: (2023)

The Heightened Risk of Fatty Liver Disorders in the Time of COVID-19
por: Stanfield, Dylan, et al.
Publicado: (2020)

Fatty Liver Disease and Cardiovascular Risk: Impact of Metabolic Dysfunctions
por: Lee, Jung Il
Publicado: (2022)

Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Schattenberg, Jörn M., et al.
Publicado: (2019)

Sarcopenia as a Novel Risk Factor for Nonalcoholic Fatty Liver Disease
por: Noh, Junghyun
Publicado: (2020)

An analysis of polygenic risk scores for non-alcoholic fatty liver disease
por: Jun, Dae Won
Publicado: (2021)

Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2018)

Fatty Liver Index (FLI) Identifies Not Only Individuals with Liver Steatosis but Also at High Cardiometabolic Risk
por: Carli, Fabrizia, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Curing Fatty Liver with Oxysterols?
por: Uehara, Kahealani, et al.
Publicado: (2022)

Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations
por: Kim, Soon Sun, et al.
Publicado: (2022)

Clinical implications of COVID-19 in patients with chronic liver disease and liver tumor
por: Gambato, Martina, et al.
Publicado: (2020)

Clinical Implication of Liver Metastasis in the Treatment of Gastric Cancer
por: Maeng, Chi Hoon
Publicado: (2023)

Are patients with alcohol-related fatty liver at increased risk of coronary heart disease?
por: Sinn, Dong Hyun, et al.
Publicado: (2014)

Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
por: Alam, Shahinul, et al.
Publicado: (2021)

Combined effects of lifestyle risk factors on fatty liver index
por: Nivukoski, Ulla, et al.
Publicado: (2020)

Multi-disciplinary clinic models for the management of non-alcoholic fatty liver disease
por: Zoncapè, Mirko, et al.
Publicado: (2022)

Diet and Exercise in the Treatment of Fatty Liver
por: Magkos, Faidon, et al.
Publicado: (2012)

Diabetes and Nonalcoholic Fatty Liver Disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

Treating fatty liver and insulin resistance
por: Perry, Rachel J., et al.
Publicado: (2013)

Glutamine, fatty liver disease and aging
por: Simón, Jorge, et al.
Publicado: (2021)

Metabolic-associated Fatty Liver Disease
por: Zheng, Ming-Hua
Publicado: (2021)

Role of fatty liver index in risk-stratifying comorbid disease outcomes in non-alcoholic fatty liver disease
por: Ho, Brian, et al.
Publicado: (2023)

Clinical implication of hepatic volumetry for living donor liver transplantation
por: Jeong, Woo Kyoung
Publicado: (2018)

Editorial: The Metabolic (Dysfunction) Associated Fatty Liver Disease (MAFLD)-Non-Alcoholic Fatty Liver Disease (NAFLD) Debate: A Forced Consensus and The Risk of a World Divide
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2022)

Metabolic dysfunction-associated fatty liver disease: from basic research to clinical application
por: Yang, Ruixu, et al.
Publicado: (2022)

Fatty Liver Disease: Metabolic, Genetic, or Both?
por: Zoller, Heinz, et al.
Publicado: (2020)

Blowing Away Fatty Liver: Mission Impossible?
por: McLean, Anna E. B., et al.
Publicado: (2021)

Diet and Lifestyle in Nonalcoholic Fatty Liver Disease
por: Martínez-Beamonte, Roberto, et al.
Publicado: (2020)

The Role of Carnitine Orotate Complex in Fatty Liver
por: Yi, Hyon-Seung
Publicado: (2021)

The Fatty Liver Index, the Strongest Risk Factor for Low Testosterone Level
por: Liu, Luna, et al.
Publicado: (2023)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
por: Gu, Weijun, et al.
Publicado: (2022)

Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
por: Basheer, Maamon, et al.
Publicado: (2023)

How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
por: Song, Byeong Geun, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease in pregnancy, paving the way for adverse pregnancy outcome risk assessment
por: Kwon, Ja-Young
Publicado: (2022)

Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time?
por: Lee, Seung Mi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6qfrvjgqpdulo7rodjtrijap78